Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia

PURPOSE: Allogeneic hematopoietic cell transplantation (HCT) after high-dose conditioning regimens imposes prohibitively high risks of morbidity and mortality for patients with high-risk acute myeloid leukemia (AML) who are older or have comorbid conditions. Here, we examined outcomes after nonmyelo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gyurkocza, Boglarka, Storb, Rainer, Storer, Barry E., Chauncey, Thomas R., Lange, Thoralf, Shizuru, Judith A., Langston, Amelia A., Pulsipher, Michael A., Bredeson, Christopher N., Maziarz, Richard T., Bruno, Benedetto, Petersen, Finn B., Maris, Michael B., Agura, Edward, Yeager, Andrew, Bethge, Wolfgang, Sahebi, Firoozeh, Appelbaum, Frederick R., Maloney, David G., Sandmaier, Brenda M.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2010
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903320/
https://ncbi.nlm.nih.gov/pubmed/20439626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.27.1460
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars